Drug intelligence / Profile preview

Shunqi Buxin Shiyiwei Pills

Development stage: Unknown
Lead developer: Inner Mongolia Mongolian Medicine
Administration: Oral

Overview

Shunqi Buxin Shiyiwei Pills is a traditional Mongolian medicine (TMM) formulation developed by the Inner Mongolia International Mongolian Medicine Hospital for the treatment of primary insomnia, specifically the "Hei-type" (wind-type) insomnia defined in Mongolian medical theory. The formulation consists of eleven ingredients and is designed to regulate "Qi" and nourish the heart. In clinical trials, it is being evaluated against zopiclone to assess its efficacy in improving sleep quality, as measured by actigraphy and sleep scales, as well as its impact on morning serum cortisol levels and safety profiles.

Brand names: Shunqi Buxin Shiyiwei Pills
Other names: Shunqi Buxin Eleven PillsShunqi Buxin 11 Pills

Beyond the preview

Go deeper on Shunqi Buxin Shiyiwei Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shunqi Buxin Shiyiwei Pills.

Explore the full profile